These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936 [TBL] [Abstract][Full Text] [Related]
5. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986 [TBL] [Abstract][Full Text] [Related]
6. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. Jackson LF; Qiu TH; Sunnarborg SW; Chang A; Zhang C; Patterson C; Lee DC EMBO J; 2003 Jun; 22(11):2704-16. PubMed ID: 12773386 [TBL] [Abstract][Full Text] [Related]
7. ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease. Beck Gooz M; Maldonado EN; Dang Y; Amria MY; Higashiyama S; Abboud HE; Lemasters JJ; Bell PD Am J Physiol Renal Physiol; 2014 Sep; 307(5):F551-9. PubMed ID: 24899059 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. Sunnarborg SW; Hinkle CL; Stevenson M; Russell WE; Raska CS; Peschon JJ; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Lee DC J Biol Chem; 2002 Apr; 277(15):12838-45. PubMed ID: 11823465 [TBL] [Abstract][Full Text] [Related]
10. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723 [TBL] [Abstract][Full Text] [Related]
12. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model. Sato K; Takaishi M; Tokuoka S; Sano S PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha converting enzyme in the human placenta throughout gestation. Hung TH; Chen SF; Hsieh CC; Hsu JJ; Li MJ; Yeh YL; Hsieh TT Reprod Sci; 2008 Feb; 15(2):195-209. PubMed ID: 18276953 [TBL] [Abstract][Full Text] [Related]
14. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Sweeney WE; Hamahira K; Sweeney J; Garcia-Gatrell M; Frost P; Avner ED Kidney Int; 2003 Oct; 64(4):1310-9. PubMed ID: 12969149 [TBL] [Abstract][Full Text] [Related]
15. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse. Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651 [TBL] [Abstract][Full Text] [Related]
16. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. Göőz M; Göőz P; Luttrell LM; Raymond JR J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974 [TBL] [Abstract][Full Text] [Related]
17. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553 [TBL] [Abstract][Full Text] [Related]